Clinical Roundup Kite announces updated data from ZUMA-3 study of KTE-X19 in adult patients with relapsed or refractory ALL December 07, 2018Vol.44 No.45
Clinical Roundup Ibrutinib + rituximab superior to standard treatment for some patients with CLL December 07, 2018Vol.44 No.45
Clinical Roundup Data from phase I/II open-label study of BCMA-directed CAR-T cell therapy lcar-b38m show tolerable safety profile, high response and MRD-negative rate in advanced r/r multiple myeloma December 07, 2018Vol.44 No.45
Clinical Roundup New long-term data on acalabrutinib in mantle cell lymphoma and CLL December 07, 2018Vol.44 No.45
Clinical Roundup Geron announces OS data from IMbark in Imetelstat-treated patients with intermediate or high-risk myelofibrosis and r/r to JAK inhibitor December 07, 2018Vol.44 No.45
Clinical Roundup Combination immunotherapy shows high activity against recurrent Hodgkin lymphoma December 07, 2018Vol.44 No.45
Clinical Roundup Karyopharm reports positive top-line phase IIb SADAL data for Selinexor in diffuse large B-cell lymphoma December 07, 2018Vol.44 No.45
Clinical Roundup Celgene announces initial phase I/II liso-cel data in patients with r/r CLL December 07, 2018Vol.44 No.45
